Back to Journals » Clinical Ophthalmology » Volume 13

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Total article views   HTML views PDF downloads Totals
5,749 Dovepress* 5,537+ 1,473 7,010
PubMed Central* 212 81 293
Totals 5,749 1,554 7,303
*Since 24 January 2019

View citations on PubMed Central and Google Scholar